Browse
related articles
Globalpharma looks to expand regional footprint with strong participation at DUPHAT 2009
- United Arab Emirates: Saturday, March 28 - 2009 at 13:29
- PRESS RELEASE
As part of its strategy to increase its market share in the Middle East, Globalpharma, a subsidiary of Dubai Investments Industries (DII) and a leading player in the regional pharmaceutical industry, has announced its strong participation at the Dubai International Pharmaceuticals and Technologies Conference Exhibition (DUPHAT) 2009.
The company will present its new range of products including antihypertensives and pain relievers, as well as a new weight loss product that will be launched in regional markets in April 2009.
This is the 3rd consecutive year that Globalpharma is participating in DUPHAT, which takes place from March 29th to 31st at the Dubai International Convention and Exhibition Centre. Globalpharma will be located at Stand I and II at the Sheikh Maktoum Hall of the exhibition centre.
"As the largest annual exhibition for the region's pharmaceutical industry, DUPHAT offers us unparalleled brand visibility and excellent networking possibilities," said Jamil Akhtar, General Manager of Globalpharma. "The event attracts the biggest names from the pharma industry and brings together key regional decision-makers, giving us an opportunity to explore strategic alliances and reinforce our relationship with health ministries and regulatory authorities from the UAE and other regional countries."
"While the global financial crisis has left virtually no economic sector completely untouched, pharmaceutical remains one of the least affected industries, and this is especially true of the pharmaceutical market in the Middle East, where analysts forecast massive, sustained growth over the next few years. Liberalization of domestic economies, combined with strong governmental efforts to encourage indigenous manufacture of pharmaceutical products, have been key growth drivers for Middle East's pharma industry," Akhtar added.
Globalpharma is Dubai's first pharmaceutical manufacturing company, manufacturing and marketing pharmaceutical products in more than 20 countries across the Middle East, Africa and Far East. Established in 1998, the company has developed into a major player in the MEA pharmaceutical market, earning a reputation for quality and reliability.
Also consider reading:
Browse
related articles
Notes and media contacts
For more information, please contact:Mitha Furtado
Headline Public Relations
Tel: 9714 - 2289655 Ext 101
Fax: 9714 - 2282125
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
Posted by Rana Mesbah
